Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$8.12 - $10.63 $56,839 - $74,410
7,000 New
7,000 $73,000
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $1,800 - $2,367
250 New
250 $1,000
Q4 2021

Feb 10, 2022

SELL
$7.9 - $10.19 $1.62 Million - $2.1 Million
-205,600 Reduced 99.81%
400 $29,000
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $1.71 Million - $2.08 Million
204,640 Added 15047.06%
206,000 $151,000
Q1 2021

May 10, 2021

BUY
$10.34 - $12.81 $13,028 - $16,140
1,260 Added 1260.0%
1,360 $107,000
Q4 2020

Feb 10, 2021

SELL
$8.61 - $11.04 $20,664 - $26,495
-2,400 Reduced 96.0%
100 $1,000
Q2 2019

Aug 13, 2019

BUY
$8.12 - $15.72 $20,299 - $39,300
2,500 New
2,500 $1,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.